The Nucleolar Protein Nucleophosmin Is Physiologically Secreted by Endothelial Cells in Response to Stress Exerting Proangiogenic Activity Both In Vitro and In Vivo.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
01 Apr 2021
Historique:
received: 01 03 2021
revised: 25 03 2021
accepted: 28 03 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 18 5 2021
Statut: epublish

Résumé

Nucleophosmin (NPM), a nucleolar multifunctional phosphoprotein, acts as a stress sensor in different cell types. NPM can be actively secreted by inflammatory cells, however its biology on endothelium remains unexplored. In this study, we show for the first time that NPM is secreted by human vein endothelial cells (HUVEC) in the early response to serum deprivation and that NPM acts as a pro-inflammatory and angiogenic molecule both in vitro and in vivo. Accordingly, 24 h of serum starvation condition induced NPM relocalization from the nucleus to cytoplasm. Interestingly, NPM was increasingly excreted in HUVEC-derived conditioned media in a time dependent fashion upon stress conditions up to 24 h. The secretion of NPM was unrelated to cell necrosis within 24 h. The treatment with exogenous and recombinant NPM (rNPM) enhanced migration as well as the Intercellular Adhesion Molecule 1 (ICAM-1) but not Vascular cell adhesion protein 1 (VCAM-1) expression and it did not affect cell proliferation. Notably, in vitro tube formation by Matrigel assay was significantly increased in HUVEC treated with rNPM compared to controls. This result was confirmed by the in vivo injection of Matrigel plug assay upon stimulation with rNPM, displaying significant enhanced number of functional capillaries in the plugs. The stimulation with rNPM in HUVEC was also associated to the increased expression of master genes regulating angiogenesis and migration, including Vascular Endothelial Growth Factor-A (

Identifiants

pubmed: 33916025
pii: ijms22073672
doi: 10.3390/ijms22073672
pmc: PMC8037380
pii:
doi:

Substances chimiques

NPM1 protein, human 0
Nuclear Proteins 0
Nucleophosmin 117896-08-9

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Marie Curie Career Career integration grant
ID : P7-PEOPLE-2011-CIG-29417
Organisme : Italian Ministry of Health
ID : RF-02362708
Organisme : AFM-Telethon
ID : 22522

Références

Cancers (Basel). 2014 Jan 27;6(1):240-96
pubmed: 24473089
Nat Immunol. 2016 Feb;17(2):122-31
pubmed: 26784265
J Clin Invest. 2012 Aug;122(8):2711-9
pubmed: 22850880
J Leukoc Biol. 2009 Sep;86(3):645-53
pubmed: 19581374
J Drug Target. 2018 Jan;26(1):27-35
pubmed: 28562134
Infect Immun. 2001 Mar;69(3):1273-9
pubmed: 11179288
J Proteome Res. 2019 Sep 6;18(9):3503-3511
pubmed: 31362508
Am J Physiol Cell Physiol. 2011 Aug;301(2):C272-9
pubmed: 21613612
Int J Cancer. 2013 Oct 1;133(7):1567-77
pubmed: 23536448
Cancer Res. 2010 Jun 1;70(11):4749-58
pubmed: 20501856
Crit Rev Immunol. 2008;28(3):229-48
pubmed: 19024347
Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6145-50
pubmed: 21444791
Free Radic Res. 2005 Dec;39(12):1335-44
pubmed: 16298863
Biochim Biophys Acta. 2009 Jun;1793(6):1008-22
pubmed: 19110011
Oncogene. 2008 May 1;27(20):2858-67
pubmed: 18037965
Cancer Cell Int. 2014 Dec 20;14(1):540
pubmed: 25663821
Clin Chem. 2003 Jan;49(1):32-40
pubmed: 12507958
J Proteome Res. 2010 Jan;9(1):179-91
pubmed: 19894763
J Immunol. 2017 Feb 15;198(4):1395-1402
pubmed: 28167650
J Biol Chem. 2004 Oct 1;279(40):41275-9
pubmed: 15310764
Nat Rev Mol Cell Biol. 2016 Oct;17(10):611-25
pubmed: 27461391
BMC Mol Biol. 2016 Aug 24;17(1):19
pubmed: 27553022
Circ Res. 2005 Oct 14;97(8):e73-83
pubmed: 16166556
J Leukoc Biol. 2014 Apr;95(4):563-74
pubmed: 24453275
J Appl Physiol (1985). 2008 Oct;105(4):1333-41
pubmed: 18599677
Ultrasound Med Biol. 2006 May;32(5):673-81
pubmed: 16677927
J Thorac Cardiovasc Surg. 2021 May;161(5):e377-e393
pubmed: 32007256
Nature. 1997 Apr 17;386(6626):671-4
pubmed: 9109485
J Cell Sci. 2005 Jan 1;118(Pt 1):211-22
pubmed: 15615785
Nucleic Acids Res. 2010 Nov;38(20):7248-59
pubmed: 20615901
BMC Complement Altern Med. 2014 Oct 27;14:420
pubmed: 25345917
Crit Care Med. 2004 Jan;32(1):77-82
pubmed: 14707562
FASEB J. 2003 Mar;17(3):333-40
pubmed: 12631573
Blood. 2010 Oct 21;116(16):3108-17
pubmed: 20664058
Cell Rep. 2015 Mar 17;10(10):1735-1748
pubmed: 25772360
Clin Ther. 2016 May;38(5):1017-28
pubmed: 27021609
Eur Surg Res. 2012;48(4):171-9
pubmed: 22653136
Sci Rep. 2015 Nov 12;5:16495
pubmed: 26559910

Auteurs

Anna Di Carlo (A)

Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Sara Beji (S)

Laboratory of Experimental Immunology, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, 00167 Rome, Italy.

Silvia Palmerio (S)

Laboratory of Experimental Immunology, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, 00167 Rome, Italy.

Mario Picozza (M)

Neuroimmunology Unit, IRCSS Fondazione Santa Lucia, 00143 Rome, Italy.

Marco D'Agostino (M)

Laboratory of Experimental Immunology, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, 00167 Rome, Italy.

Vincenzo Petrozza (V)

Department of Medical Surgical Sciences and Biotechnologies, Sapienza University, 04100 Latina, Italy.

Roberta Melchionna (R)

Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Antonia Germani (A)

Laboratory of Experimental Immunology, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, 00167 Rome, Italy.

Alessandra Magenta (A)

Institute of Translational Pharmacology (IFT), Consiglio Nazionale delle Ricerche (CNR), 00133 Rome, Italy.

Elena De Falco (E)

Department of Medical Surgical Sciences and Biotechnologies, Sapienza University, 04100 Latina, Italy.
Mediterranea Cardiocentro, 80122 Naples, Italy.

Daniele Avitabile (D)

Department of Scientifico e Sviluppo, IDI Farmaceutici, Via dei Castelli Romani 73/75, 00071 Pomezia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH